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In a casual perusal of papers on hypertension, one
comes across well over a hundred so-called hypo-
tensive remedies alleged to possess the property of
lowering the blood pressure. In 1930, Ayman could
collect over two hundred reports on the successful
treatment of hyperpiesia by various hypotensive
-remedies.
In view of the persistently high mortality from
hypertension in spite ofthe large number ofmeasures
recommended in the treatment of this disease one is
forced to admit the futility or helplessness of the
situation. In Ayman's opinion, the " proper
treatment is still unknown." Evans and Loughnan,,
after a critical analysis and trial of thirty-three
different preparations in seventy cases of high blood
pressure (essential hypertension), were forced to
admit the uselessness of them all. In their opinion,
simple sedative measures are often more effective
than the much more expensive and fashionable
products extensively displayed on the market.
There is unfortunately, a great tendency on the
part of both the medical profession and the laiety,
to hail or applaud any new drug or measure intro-
duced into the market, often on the basis of a few
stray experiences or clinical impressions. In
consequence of this attitude, many of the present
day clinicians have learnt not to accept any claim
for a new remedy unless and until its therapeutic
value has been firmly established by resort to
carefully controlled clinical observations.
My selection of R. Serpentina for the present
study has not been entirely fortuitous. I have
been prompted into the present enquiry by several
factors. In the short span of ten years that the
dried root of R. Serpentina has been on the market
in India, in tablet form, there has been a growing
demand in this country for these tablets. Prepara-
tions of the serpentina root have gained such un-
precedented popularity for hypertension cases in
this country, that there is hardly a patient with
high blood pressure who has not been subjected to
its effects in one form or another. One manu-
facturing firm alone claims to have sold over 50 mil-
lion tablets of the dried root.- One of the aims of
the present investigations has therefore been to
determine if this enthusiastic reception of the drug
is warranted. As early as 1940, I had made the
following allusion to the subject of R. Serpentina
treatment in cases of hypertension: " After a trial
of this preparation one finds it useful in a percentage
of cases of hypertension only; the indications and
suitability of the case for the drug have not as yet
been worked out." Since that time, I have had the
opportunity of observing the effects of this drug in a
very large number of cases. After an extensive
trial of various hypotensive remedies in several
thousand cases of hypertension, both in private and
hospital practice during the last ten years, I have
found R. Serpentina to be the most consistently
successful member qf the whole group of hypo-
tensive remedies. In reply to a recent questionnaire
issued by me to fifty physicians from all over India,
forty-six voted for R. Serpentina as being the best
"hypotensive " in their experience.
In view of this overwhelming body of support in
favour of regarding R. Serpentina as the remedy of
choice, I have considered it opportune to subject
this preparation to a more critical analysis and to
try and form an unbiased opinion of its value as a
hypotensive agent. In the present investigation I
have tried to steer clear of those fallacies involved in
the interpretation of therapeutic results, to which
particular attention has been drawn by Ayman,
Kapernick, and others. There is an unfortunate
tendency to claim success in the treatment of essen-
tial hypertension merely on the basis of symptomatic
improvement. In the opinion of Ayman, the suc-
cessful treatment of hyperpiesia, implies, of neces-
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sity, a substantial reduction in the level of the blood
pressure. In Kapernick's opinion, " although
symptomatic response is relatively easily obtained,
reduction of blood pressure is difficult." This
has been the experience also ofEvans and Loughnan,
who found that although good symptomatic relief
can be obtained in cases of hypertension with a
large number of remedies, the much more desirable
hypotensive effect is rarely noted. The factor of
natural lability of the blood pressure, so common
in hypertensives, is often lost sight of, in the inter-
pretation of results; as a result, perfectly normal or
natural fluctuations are mistaken or misconstrued
for evidences of the therapeutic value of the drug
under trial.
According to Evans and Loughnan, any remedy
before it can be accepted as having established a
claim as a hypotensive agent must satisfy certain
standards of efficiency, viz. (1) it should be capable
both of reducing a blood pressure that is high and of
maintaining it at the lowered value; (2) it should be
able to exhibit its hypotensive action consistently
and in a high proportion of patients; and (3) it
should be free of all toxic ill-effects.
AN INTRODUCTION TO RAUWOLFIA SERPENTINA
The use of vegetable extracts in the treatment of
high blood pressure is not new. Both, watermelon
seeds and the mistletoe plant have been tried in the
past, without gaining general endorsement. In
1939, Graham had reported benefit in cases of
hypertension from the use of the tincture of haw-
thorne (Cratagus oxycantha).
R. Serpentina (variously known in India as
sarpagandha, chandrika, chotachand, chandra,
dhanmarna, dhan-barua, patala-gandhi, and cova-
namilpori) or the Serpentina plant is a large climbing
or twining herb or shrub, belonging to the natural
order Apocynaceae, and found in the Himalayas,
in Assam, Pegu, Tennasserim, Java, the Deccan
peninsula, and the Malaya peninsula.
The root of this plant has been popular, both in
India and in the Malay peninsula, from ancient
times, as an antidote to the stings and bites of
insects and poisonous reptiles. It has been used
also as a febrifuge, as a stimulant to uterine con-
tractions, for insomnia, and most of all for insanity.
More recently, its clinical application has been
extended, with success, to cases of high blood
pressure.
Early researches on R. Serpentina showed that
it contained an alkaloid which was provisionally
called pseudobrucine. On account of its popularity
with practitioners of indigenous medicine, the
chemical composition of the serpentina plant has
been subjected to considerable scrutiny. Sen and
Bose (1931) discovered two alkaloids in its root, the
total alkaloid content being about 1 per cent of the
dried root, there being also a lot of resin and
starch. Siddiqui and Siddiqui (1931) found, besides
phytosterol, oleic acid, and unsaturated alcohols,
five alkaloids, which were classified by them into
two groups, viz. (1) The ajmaline group of three
white crystalline, weak bases, ajmaline, ajmalinine,
ajmalicine; and (2) the serpentine group of two
yellow crystalline stronger bases, serpentine and
serpentinine.
On the basis of experiments on frogs, Siddiqui
and Siddiqui showed that the ajmaline group acts
as a general depressant to the heart, respiration, and
central nervous system, whilst the serpentine group
causes paralysis of respiration, depression of nerves,
and stimulation of the heart. Sen and Bose studied
the pharmacological effects of the R. Serpentina
alkaloids on cats and other higher animals. They
reported a small drop of blood pressure, a stimula-
tion of the respiration, a depression of the heart
muscle and a relaxation of plain -muscle-tissue (e.g.
of the uterus and intestines). Roy (1931) found
that large doses induce sleep, cause dulling of sensa-
tions and diminution of reflexes. Fatal doses
caused death from respiratory failure the heart
continuing to beat for some time after. Chopra
has been engaged in pharmacological researches on
the R. Serpentina since 1932, but the results of his
work are not as yet known. It is claimed by certain
manufacturers that the root from a well-reared and
scientifically cultivated serpentina plant yields about
three times more of the active alkaloids than the
root from the wild plant, which is thinner, more
stunted and often marred by exposure to the sun,
rain, and frost.
On the basis of experimental and clinical studies,
the root of R. Serpentina is said to have the following
pharmacological attributes. (1) By action on the
vaso-motor centre, it leads to generalized vaso-
dilatation, with a lowering of blood pressure.
(2) By depressant action on the cerebral centres, it
soothes the general nervous system. (3) It exerts
a sedative action on the gastric mucosa and. a
stimulating action on the plain musculature of the
intestinal tract. (4) It stimulates the bronchial
musculature.
A vague reference to the use of a tincture or
alcoholic extract of the root of R. Serpentina, in
cases of high blood pressure, was made in 1942 by
Paranjpe. He claimed improvement, without any
statistical backing, in most cases of hypertension;
the hypotensive action was said to be particularly
gratifying in elderly subjects- and in the case of the
diastolic pressure; the tincture was said to be a
351
R. J. VAKIL
good cough-sedative and diuretic. In two cases
reported by Paranjpe, there had been a permanent
reduction of blood pressure for well over a year, on
occasional doses of the tincture.
METHOD OF INVESTIGATION
Selection of patients. The fifty patients for
investigation were selected from amongst a large
number of cases of essential hypertension, who
reported regularly at the clinic for treatment and
who showed their willingness to co-operate. The
diagnosis of essential hypertension was accepted on
the basis of a routine clinical examination and
investigations including urine analysis, ophthalmo-
scopic examination, orthodiagraphy, electrocardio-
graphy, and (in some cases) renal function tests and
teleradiography. Only patients with systolic pres-
sure over 160 and diastolic over 95 mm. were
admitted into this series. Cases of nephritic or
renal hypertension, secondary hypertension, and
malignant hypertension (diagnosed on the basis of
clinical and ocular criteria) were rigidly excluded.
Of the 50 patients selected for study, 30 were males
and 20 females, ranging in age from 39 to 76 years,
the average age for the series being 59 years.
Each patient was instructed to report for examina-
tion periodically, according to a rigid and pre-
arranged plan. The routine adopted in each case
was identical, viz. after an initial examination
and check-up of the blood pressure (reading A),
the patient was kept on a sedative capsule (contain-
ing 0,25 grains of prominal or phemitone) given
three times daily for two weeks, the blood pressure
being recorded again (reading B) and accepted as
the actual " pre-treatment" level. This prepara-
tory period of sedation exerts in my opinion a sort
of stabilizing influence on the blood pressure of
hypertensives, especially in those with hypersensitive
nervous systems. Administration of R. Serpentina
tablets (one serpina tablet three times a day after
meals) was then started, this dose being kept up for
four weeks. The only other preparations per-
mitted, during R. Serpentina therapy, were laxatives,
insulin injections (in diabetics), and occasionally
tablets of aspirin for headaches. During serpina
treatment, the blood pressure was checked and
recorded once weekly (readings C, D, E, and F).
In a few of my cases, the fall was so precipitate that
further treatment had to be discontinued. After
four weeks of-serpina treatment, all medication was
stopped for four weeks; during this interval or
period of no treatment, the blood pressure was
recorded twice, at fortnightly intervals (readings G
and H). A second course of serpina tablets (in the
same doses) was then started and continued for
two weeks; at the end of this course, the blood
pressure was recorded for the last time (reading J).
The following nine sets of blood pressure readings
were, therefore, recorded in each case: (A) at start
of investigation, (B) after two weeks of sedative
therapy, (C) after one week of serpina therapy,
(D) after two weeks of therapy, (E) after three
weeks of therapy, (F) after four weeks of therapy,
(G) after a fortnight of no medication, (H) after
four weeks of no medication, and (J) after two weeks
of serpina treatment (second course).
The ritual observed at each check-up of the
patient was properly standardized. At each atten-
dance (arranged between the hours of 3 and 6 p.m.),
the patient was made to rest in the waiting room for
about half an hour. After a short history of symp-
toms and an enquiry for toxic reactions, the patient
was subjected to a thorough clinical examination.
The blood pressure was recorded in the recumbent
posture with the aid of a new Baumanometer, in
accordance with the suggestions of the joint British
and American Committees for standardization.
Of three consecutive readings at each sitting, only
the third or last was accepted for recording purposes.
All the observations reported here were made by me
using the same instrument throughout.
In the present investigation, I have not con-
cerned myself much with the improvement in
individual symptoms, reported by patients, such a
determination being liable to errors of interpretation.
In any case, the symptomatic status of such a case
bears little or no relationship to the level of the
blood pressure.
In the presentation of results, all rises or falls of
systolic blood pressure of less than 10 mm. and of
the diastolic of less than 5 mm. have been classified
as " insignificant," rises or falls of systolic pressure
between 10 and 24 mm. and of the diastolic between
5 and 14 mm. as " moderate " and rises or falls of
the systolic exceeding 25 mm. and of the diastolic
exceeding 15 mm. have been classified as "marked."
RESULTS OF INVESTIGATION
After two weeks of sedative therapy. After two
weeks 28 of 50 patients showed a drop of systolic
pressure ranging from 2 to 12 mm., the average fall
being 6 mm. In 17 of the cases there was a rise
ranging from 2 to 14 mm., with an average of 4 mm.
In the remaining 5 cases, there was no alteration at
all. Taking all 50 cases into consideration, the
average drop of systolic blood pressure after two
weeks of sedation works out at under 2 mm.
In the case of the diastolic blood pressure, there
was a fall in 30 cases ranging from 2 to 8 mm.
with an average of 3 mm.; in 7 cases there wa
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an actual rise ranging from 2 to 10 mm., with an
average of 4 mm.
AFTER ONE WEEK OF R. SERPENTINA THERAPY
The immediate response of the blood pressure to
R. Serpentina therapy is shown in Table I.
TABLE I
In 35 of my 48 cases, there was a drop of both
systolic and diastolic pressure, after one week of
drug treatment; in 6 cases there was a paradoxical
rise of both systolic and diastolic pressure whilst
in the remaining 6 cases there was a rise of one with
a fall of the other.
AFTER FOUR WEEKS OF R. SERPENTINA THERAPY
CHANGES OF SYSTOLIC AND DIASTOLIC BLOOD PRESSURE The delayed response of the blood pressure to
AFTER ONE WEEK OF R. SERPENTINA THERAPY drug therapy is given in Table II.
Systolic blood Diastolic
Extent of alteration pressure blood pressure
in blood pressure _
No. of Per No. of Per
cases cent cases cent
From+10to +6mm. 1 2 1 2
+5 to +1 mm. 8 17 8 17
No change- 2 4 4 8
-I to -4mm. 7 15 18 38
-5 to -9 mm. I 1 23 12 25
-10 to -14mm. 7 15 4 8
-15 to-l9mm. 2 4 1 2
-20 to-24 mm. 5 10 0 0
-25 to-29 mm. 2 4 0 0
-30 to-34 mm. 2 4 0 0
-35to-40mm. 1 2 0 0
From+ 10 to-40 mm. 48 100 48 100
Systolic blood pressure. Of the 48 cases studied
(two of our patients having absented themselves),
as many as 37 cases showed a drop of systolic
pressure, ranging from 2 to 38 mm. with an average
drop of 13 mm. In 2 cases it remained unaltered
whilst in 9 there was actually a paradoxical rise,
ranging from 2 to 6 mm. with an average rise of
3 mm.
A " moderate" fall (i.e. 10 to 24 mm.) was noted
in 14 out of 48 cases and a " marked " fall (i.e.
25 mm. or over) in 5 cases. In other words, of my
48 cases, 19 cases (or 39 5 per cent) showed a response
within a week of commencement of serpina
treatment.
Diastolic blood pressure. Of the 48 cases, 35
showed a fall of diastolic pressure ranging from
2 to 18 mm., with an average of 6 mm.; in 4 cases
the diastolic level remained unaffected whilst in
9 there was an actual rise ranging from 2 to 6 mm.
with an average of 3 mm.
The diastolic fall was classified as being of
" moderate" degree (i.e. 5 to 14 mm.) in 16 cases
and as " marked " (i.e. 15 mm. or over) in 1 case.
A good result (i.e. a diastolic drop of 5 mm. or
more) was therefore obtained in 17 cases. (See
Table I.)
2B
TABLE IL
CHANGES OF SYSTOLIC AND DIASTOLIC BLOOD PRESSURE
AFTER FOUR WEEKS OF R. SERPENTINA THERAPY
Systolic blood Diastolic
Extent of alteration in pressure blood pressure
blood pressure l _
No. of Per No. of Per
cases cent cases cent
From +20 to +llmm. 1 2 0 0
+10to +1mm. 6 13 6 13
No change- 0 0 3 7
-Ito -9mm. 5 11 17 36
-lO to-19 mm. 14 30 18 38
-20 to-29 mm; 9 19 2 4
-30 to-39 mm. 10 21 1 2
-40 to-49 mm. 1 2 0 0
-50 to-60 mm. 1 2 0 0
From + 20 to -60 mm. 47 100 47 100
Systolic blood pressure. Of the 47 cases studied
(three failed to report for check-up), as many as
40 responded to serpina therapy by showing a drop
of systolic pressure, ranging from 2 to 54 mm. with
an average of 21 mm. A rise of 4 to 12 mm., with
an average of 6 mm. was noted in the remaining
7. Taking all the cases into consideration, the
average fall worked out at 19 mm., with a range
of +12 to -54 mm.
The systolic fall was described as being
"moderate " in 22 cases out of47 and as " marked "
in 13 cases. In other words, a good systolic response
(i.e. 10 mm. or over) was noted in 35 of 47 cases,
after four weeks of serpina therapy.
Diastolic bloodpressure. In 38 out of the 47 cases
there was a drop of diastolic pressure ranging from
4 to 34 mm., with an average of 11 mm.; in 3 cases,
the diastolic level remained unaltered whilst in
6 cases there was an actual rise varying between
2 and 10 mm., the average being 5 mm. Taking
all cases into consideration, the diastolic pressure
showed an average drop of 10 mm., the range of
variation being from +10 to -34 mm.
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The diastolic fall, after four weeks of therapy,
could be classified as " moderate " in 27 of the
47 cases and as " marked " in 7 cases. A good
diastolic response (i.e. 5 mm. or over) was therefore
obtained in as many as 34 out of 47 cases.
In as many as 29 of my 47 cases there was a
"moderate" or " marked" fall of both systolic
and diastolic pressures; in 6 cases such improve-
ment was confined to systolic levels only, and in
2 to the diastolic levels only.
Types of blood pressure response, during R.
Serpentina therapy. According to the rapidity and
degree of fall of the systolic blood pressure during
drug treatment, I have been able to recognize five
main types of blood pressure curves. (1) A gradual
fall continued throughout the course of treatment
(21 ofmy 50 cases). (2) The plateau type, where the
systolic level showed little or no alteration through-
out treatment (12 cases). (3) A precipitate initial
drop with a gradual decline subsequently (8 cases).
(4) An initial plateau with subsequently, a gradual
decline (5 cases). (5) A precipitate initial drop
with subsequently a plateau (3 cases).
From the behaviour of the pressure (especially
systolic), a graph can easily be constructed to deter-
mine the type of response to drug treatment, in any
given case.
AFTER CESSATION OF R. SERPENTINA THERAPY
These studies were undertaken with a view to
determine whether the hypotensive action of
serpina is strictly limited to the period of its ad-
ministration or whether it is continued for some time
after.
After two weeks. The persistence of the hypo-
tensive action of R. Serpentina was studied in the
41 cases in my series, who had responded to its
administration by a fall of blood pressure; un-
fortunately, 5 of these having failed to report for
their periodical check-up, our enquiry has had to be
limited to a total of 36 cases. Two weeks after
stoppage of serpina treatment, the results were as
follows. In 22 of the 36 cases the low levels induced
by serpina tablets were well maintained; in 8 cases
they were partially maintained; in 3 cases they had
returned to their levels of before treatment; in the
remaining 3 cases there was a further fall.
After four weeks. Thirty-nine cases could be
investigated from this point of view. The results
were as follows. In 10 the low levels were well
maintained; in 15 cases they were partially main-
tained; in 10 cases they had returned to the level
before treatment; in 4 cases the pressure showed a
further drop. The hypotensive action of R.
Serpentina was, therefore, perceptible in 91 per cent
of my cases for two weeks and in 74 per cent for
four weeks after discontinuance of the drug.
AFTER A SECOND COURSE OF R. SERPENTINA
In order to test the drug for consistency of action,
all the 50 cases of my series were subjected to a
second course of serpina tablets after an interval of
four weeks. The tablets were administered in
the same doses, but for two weeks only. The
results of this second course were most satisfactory,
making allowance for the fact that as many as
36 per cent of the cases were still under the hypo-
tensive influence of the first course of tablets. The
average drop of systolic blood pressure after the
first course had worked out at 17 mm., the maximum
fall recorded in any case being 44 mm. In the case
of the diastolic pressure, the corresponding values
worked out at 7 mm. and 22 mm. respectively.
After two weeks of the second course, the average
systolic fall worked out at 10 mm., the maximum
drop in any case being 24 mm. The corresponding
values for the diastolic pressure were 5 mm. and
12 mm. respectively.
The blood pressure behaviour after the second
course of tablets was very similar to that after the
first, in the great majority of the cases. However,
in one case there was a drop of pressure during the
first course but a rise during the second; the
reverse happened in one case.
Toxic EFFECTS AND REACTIONS FROM R.
SERPENTINA
After having used the dried root of R. Serpentina
in several thousand cases of high blood pressure,
both in hospital and private practice, I can vouch
for the non-toxicity of the drug with confidence;
I have, so far, not come across a single fatality
from the administration of this preparation. Even
when the administration has been continued without
a break for as long as two to five years (as in some of
my cases), and even in the presence of cardiac or
renal complications, there have been no ill-effects
of a serious disabling or permanent nature.
The following reactions were reported by some
of my cases, during the present investigation.
Excessive drowsiness or " sleepiness "
Feeling of depression or lassitude . .
Diarrhcea .. ..
Anorexia .. ..
Nausea and vomiting ..
Vertigo or giddiness . .
Increase of polyuria and nocturia . .
Abdominal griping pain
6 cases
4 cases
3 cases
2 cases
2 cases
2 cases
2 cases
1 case
The commonest disturbance after R. Serpentina
administration, in my experience, has been that of
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excessive drowsiness or sleep; to some of the
hypertensives suffering from insomnia, this may
prove a blessing in disguise. Diarrhoam is usually
of a mild order and responds readily to treatment.
On the whole, R. Serpentina preparations are very
well tolerated by patients and appear non-toxic
in therapeutic doses. The only contra-indications,
in my opinion, are severe or intractable diarrhoeas
or dysenteries and cases of hypertension of renal or
malignant type, where this form of treatment proves
of no avail.
At the present time, R. Serpentina preparations,
as manufactured in India, have one serious draw-
back to their use; not being properly standardized
or assayed, the hypotensive action of the drug is
not strictly constant from batch to batch of the
drug. For some time now, the physicians of this
country have felt the need for a more satisfactory
and standard preparation of this drug, the action
of which can be predicted at all times.
SUMMARY AND CONCLUSIONS
The hypotensive action of Rauwolfia Serpentina
(N.O. Apocynacae) has been subjected to clinical
trial in a series of fifty cases of essential benign
hypertension. Tablets of the dried root of this
plant were prescribed in optimum doses, the patients
being subjected to periodical check-ups of the blood
pressure, according to a pre-arranged plan.
Within a week of R. Serpentina therapy, 77 per
cent of my cases showed a drop of systolic blood
pressure ranging from 2 to 38 mm., with an average
drop of 13 mm. A drop of 10 mm. or over was
noted in 40 per cent of cases.
In the case of the diastolic blood pressure, 73 per
cent of cases displayed a drop ranging from 2 to
18 mm., with an average drop of 6 mm.; a diastolic
response of 5 mm. or over was noted in 35 per cent.
In 73 per cent of cases, there was a drop of both
systolic and diastolic blood pressure after one week
of therapy.
After four weeks of R. Serpentina therapy,
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85 per cent of cases displayed a drop of systolic
blood pressure varying from 2 to 54 mm. with an
average of 21 mm. A systolic drop of 10 mm.
or over was noted in as many as 74 per cent of
cases.
In 81 per cent of cases, the diastolic pressure
showed a drop of 4 to 34 mm. with an average of
11 mm. A diastolic fall of 5 mm. or over was
noted in 72 per cent.
In 62 per cent of cases there was a " moderate"
or "' marked " drop of both systolic and diastolic
pressure levels.
According to the behaviour of the blood pressure,
I was able to recognize five types of response to
R. Serpentina therapy, which have been described.
The hypotensive action was apparent in 91 per
cent of cases two weeks after stoppage of all treat-
ment and in 74 per cent even after four weeks of no
treatment.
A second course, of two weeks, was tried in all
the cases after an interval of four weeks; the blood
pressure response to the second course of tablets
was almost as good as during the first.
R. Serpentina appears to be a perfectly safe remedy,
devoid of any serious or toxic ill-effects. Amongst
the few -unpleasant symptoms encountered during
its administration, were excessive drowsiness (in
12 per cent), lassitude (in 8 per cent), diarrhoea (in
6 per cent), anorexia (in 4 per cent) and nausea with
vomiting (in 4 per cent).
On the whole, the results of R. Serpentina therapy,
in the present series, have been most encouraging.
In most cases it was proved capable of lowering both
systolic and diastolic blood pressure. Although its
action is temporary in many cases, it can be repro-
duced successfully by a second administration of the
drug. No serious reactions to therapy were en-
countered in any of the cases. R. Serpentina,
therefore, satisfies all the criteria of a successful
hypotensive agent formulated by Evans and
Loughnan (1939). Judging from the results of the
present investigation, it has a definite place in the
treatment of cases of high blood pressure.
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